Smart Immune to Present ReSet-02 Phase I Preliminary Data and the Determination of the Recommended Dose at ASH 2024
November 5, 2024
On the occasion of its selection among the French Tech Health 20 winners, Karine Rossignol, CEO and Jérémy CFO/CBO were interviewed by various media.
Quote in Les Echos
Quote in Le Figaro
Article in Biotech Finances
TV appearance in BFM Tech&Co